The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Tachycardia, Ventricular

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Tachycardia, Ventricular


Psychiatry related information on Tachycardia, Ventricular


High impact information on Tachycardia, Ventricular


Chemical compound and disease context of Tachycardia, Ventricular


Biological context of Tachycardia, Ventricular


Anatomical context of Tachycardia, Ventricular


Gene context of Tachycardia, Ventricular


Analytical, diagnostic and therapeutic context of Tachycardia, Ventricular


  1. Sotalol. Hohnloser, S.H., Woosley, R.L. N. Engl. J. Med. (1994) [Pubmed]
  2. A double-blind trial of metoprolol in acute myocardial infarction. Effects on ventricular tachyarrhythmias. Rydén, L., Ariniego, R., Arnman, K., Herlitz, J., Hjalmarson, A., Holmberg, S., Reyes, C., Smedgård, P., Svedberg, K., Vedin, A., Waagstein, F., Waldenström, A., Wilhelmsson, C., Wedel, H., Yamamoto, M. N. Engl. J. Med. (1983) [Pubmed]
  3. Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy. Maron, B.J., Shen, W.K., Link, M.S., Epstein, A.E., Almquist, A.K., Daubert, J.P., Bardy, G.H., Favale, S., Rea, R.F., Boriani, G., Estes, N.A., Spirito, P. N. Engl. J. Med. (2000) [Pubmed]
  4. Cardiac actions of antihistamines. Woosley, R.L. Annu. Rev. Pharmacol. Toxicol. (1996) [Pubmed]
  5. Comparison of procainamide and mexiletine in prevention of ventricular arrhythmias after acute myocardial infarction. Campbell, R.W., Dolder, M.A., Prescott, L.F., Talbot, R.G., Murray, A., Julian, D.G. Lancet (1975) [Pubmed]
  6. Effect of landiolol on nonsustained ventricular tachycardia during electroconvulsive therapy. Kim, C., Sakamoto, A., Ogawa, R. Anesth. Analg. (2005) [Pubmed]
  7. Critical care providers' perceptions of the use of vasopressin in cardiac arrest. Heath, J., Hanson, D., Long, R., Crowell, N.A. Am. J. Crit. Care (2005) [Pubmed]
  8. Facilitating transthoracic cardioversion of atrial fibrillation with ibutilide pretreatment. Oral, H., Souza, J.J., Michaud, G.F., Knight, B.P., Goyal, R., Strickberger, S.A., Morady, F. N. Engl. J. Med. (1999) [Pubmed]
  9. Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure. Singh, S.N., Fletcher, R.D., Fisher, S.G., Singh, B.N., Lewis, H.D., Deedwania, P.C., Massie, B.M., Colling, C., Lazzeri, D. N. Engl. J. Med. (1995) [Pubmed]
  10. Nifedipine therapy for coronary-artery spasm. Experience in 127 patients. Antman, E., Muller, J., Goldberg, S., MacAlpin, R., Rubenfire, M., Tabatznik, B., Liang, C.S., Heupler, F., Achuff, S., Reichek, N., Geltman, E., Kerin, N.Z., Neff, R.K., Braunwald, E. N. Engl. J. Med. (1980) [Pubmed]
  11. Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs. Makkar, R.R., Fromm, B.S., Steinman, R.T., Meissner, M.D., Lehmann, M.H. JAMA (1993) [Pubmed]
  12. Ventricular tachycardia after terbutaline. Kinney, E.L., Trautlein, J.J., Harbaugh, C.V., Lambert, D., Zelis, R.F. JAMA (1978) [Pubmed]
  13. Clinical efficacy and electrophysiology during long-term therapy for recurrent ventricular tachycardia or ventricular fibrillation. Heger, J.J., Prystowsky, E.N., Jackman, W.M., Naccarelli, G.V., Warfel, K.A., Rinkenberger, R.L., Zipes, D.P. N. Engl. J. Med. (1981) [Pubmed]
  14. Interaction between quinidine and digoxin. Leahey, E.B., Reiffel, J.A., Drusin, R.E., Heissenbuttel, R.H., Lovejoy, W.P., Bigger, J.T. JAMA (1978) [Pubmed]
  15. Effects of verapamil on ventricular tachycardias possibly caused by reentry, automaticity, and triggered activity. Sung, R.J., Shapiro, W.A., Shen, E.N., Morady, F., Davis, J. J. Clin. Invest. (1983) [Pubmed]
  16. Right ventricular outflow tract tachycardia due to a somatic cell mutation in G protein subunitalphai2. Lerman, B.B., Dong, B., Stein, K.M., Markowitz, S.M., Linden, J., Catanzaro, D.F. J. Clin. Invest. (1998) [Pubmed]
  17. Relative efficacy and safety of intravenous drugs for termination of sustained ventricular tachycardia. Griffith, M.J., Linker, N.J., Garratt, C.J., Ward, D.E., Camm, A.J. Lancet (1990) [Pubmed]
  18. Autonomic control of ventricular tachycardia: sympathetic neural influence on spontaneous tachycardia 24 hours after coronary occlusion. Martins, J.B. Circulation (1985) [Pubmed]
  19. Antiarrhythmic efficacy and hemodynamic effects of cibenzoline in patients with nonsustained ventricular tachycardia and left ventricular dysfunction. Seals, A.A., Haider, R., Leon, C., Francis, M., Young, J.B., Roberts, R., Pratt, C.M. Circulation (1987) [Pubmed]
  20. Action potential alternans and irregular dynamics in quinidine-intoxicated ventricular muscle cells. Implications for ventricular proarrhythmia. Karagueuzian, H.S., Khan, S.S., Hong, K., Kobayashi, Y., Denton, T., Mandel, W.J., Diamond, G.A. Circulation (1993) [Pubmed]
  21. A missense mutation in a highly conserved region of CASQ2 is associated with autosomal recessive catecholamine-induced polymorphic ventricular tachycardia in Bedouin families from Israel. Lahat, H., Pras, E., Olender, T., Avidan, N., Ben-Asher, E., Man, O., Levy-Nissenbaum, E., Khoury, A., Lorber, A., Goldman, B., Lancet, D., Eldar, M. Am. J. Hum. Genet. (2001) [Pubmed]
  22. Polymorphic ventricular tachycardia induced by programmed stimulation: response to procainamide. Buxton, A.E., Josephson, M.E., Marchlinski, F.E., Miller, J.M. J. Am. Coll. Cardiol. (1993) [Pubmed]
  23. The effects of doxorubicin on ventricular tachycardia. le Marec, H., Spinelli, W., Rosen, M.R. Circulation (1986) [Pubmed]
  24. Diagnostic value of plasma levels of brain natriuretic peptide in arrhythmogenic right ventricular dysplasia. Matsuo, K., Nishikimi, T., Yutani, C., Kurita, T., Shimizu, W., Taguchi, A., Suyama, K., Aihara, N., Kamakura, S., Kangawa, K., Takamiya, M., Shimomura, K. Circulation (1998) [Pubmed]
  25. Differential effects of heptanol, potassium, and tetrodotoxin on reentrant ventricular tachycardia around a fixed obstacle in anisotropic myocardium. Brugada, J., Mont, L., Boersma, L., Kirchhof, C., Allessie, M.A. Circulation (1991) [Pubmed]
  26. Termination of ventricular tachycardia by an increase in cardiac vagal drive. Waxman, M.B., Wald, R.W. Circulation (1977) [Pubmed]
  27. Autonomic nervous system activity and the spontaneous initiation of ventricular tachycardia. ESVEM Investigators. Electrophysiologic Study Versus Electrocardiographic Monitoring Trial. Shusterman, V., Aysin, B., Gottipaty, V., Weiss, R., Brode, S., Schwartzman, D., Anderson, K.P. J. Am. Coll. Cardiol. (1998) [Pubmed]
  28. Functional characterization of a trafficking-defective HCN4 mutation, D553N, associated with cardiac arrhythmia. Ueda, K., Nakamura, K., Hayashi, T., Inagaki, N., Takahashi, M., Arimura, T., Morita, H., Higashiuesato, Y., Hirano, Y., Yasunami, M., Takishita, S., Yamashina, A., Ohe, T., Sunamori, M., Hiraoka, M., Kimura, A. J. Biol. Chem. (2004) [Pubmed]
  29. Denaturing HPLC-based approach for detecting RYR2 mutations involved in malignant arrhythmias. Bagattin, A., Veronese, C., Bauce, B., Wuyts, W., Settimo, L., Nava, A., Rampazzo, A., Danieli, G.A. Clin. Chem. (2004) [Pubmed]
  30. Characterization of a novel missense mutation in the pore of HERG in a patient with long QT syndrome. Yoshida, H., Horie, M., Otani, H., Takano, M., Tsuji, K., Kubota, T., Fukunami, M., Sasayama, S. J. Cardiovasc. Electrophysiol. (1999) [Pubmed]
  31. Catecholamine-provoked microvoltage T wave alternans in genotyped long QT syndrome. Nemec, J., Ackerman, M.J., Tester, D.J., Hejlik, J., Shen, W.K. Pacing and clinical electrophysiology : PACE. (2003) [Pubmed]
  32. Ryanodine receptor mutations associated with stress-induced ventricular tachycardia mediate increased calcium release in stimulated cardiomyocytes. George, C.H., Higgs, G.V., Lai, F.A. Circ. Res. (2003) [Pubmed]
  33. Adjuvant xamoterol or metoprolol in patients with malignant ventricular arrhythmia resistant to amiodarone. Paul, V., Griffith, M., Ward, D.E., Camm, A.J. Lancet (1989) [Pubmed]
  34. Exercise-triggered paroxysmal ventricular tachycardia. A repetitive rhythmic activity possibly related to afterdepolarization. Wu, D., Kou, H.C., Hung, J.S. Ann. Intern. Med. (1981) [Pubmed]
  35. Adenosine-sensitive ventricular tachycardia. Clinical characteristics and response to catheter ablation. Wilber, D.J., Baerman, J., Olshansky, B., Kall, J., Kopp, D. Circulation (1993) [Pubmed]
  36. Long-term reproducibility of ventricular tachycardia induction in patients with implantable cardioverter/defibrillators. Serial noninvasive studies. Gillis, A.M., Sheldon, R.S., Wyse, D.G., Leitch, J.W., Yee, R., Klein, G.J., Duff, H.J., Mitchell, L.B. Circulation (1995) [Pubmed]
  37. Efficacy and safety of moricizine in patients with ventricular tachycardia: results of a placebo-controlled prospective long-term clinical trial. Pratt, C.M., Wierman, A., Seals, A.A., English, L., Leon, C., Young, J.B., Quinones, M.A., Roberts, R. Circulation (1986) [Pubmed]
WikiGenes - Universities